Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)

ClinicalTrials.gov ID: NCT00078403

Public ClinicalTrials.gov record NCT00078403. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 8:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Suppressive Long-Term Antiviral Management of Hepatitis C Virus (HCV) and HIV-1 Coinfected Subjects (SLAM-C)

Study identification

NCT ID
NCT00078403
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
333 participants

Conditions and interventions

Interventions

  • Peginterferon alfa-2a Drug
  • Ribavirin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2004
Primary completion
Apr 30, 2007
Completion
Jan 31, 2009
Last update posted
Nov 7, 2021

2004 – 2009

United States locations

U.S. sites
36
U.S. states
18
U.S. cities
26
Facility City State ZIP Site status
Alabama Therapeutics CRS Birmingham Alabama 35924-2050
University of Southern California CRS Los Angeles California 90033-1079
UCLA CARE Center CRS Los Angeles California 90035
Stanford AIDS Clinical Trials Unit CRS Palo Alto California 94304-5350
UCSD Antiviral Research Center CRS San Diego California 92103
Ucsf Hiv/Aids Crs San Francisco California 94110
Santa Clara Valley Med. Ctr. San Jose California 95128
University of Colorado Hospital CRS Aurora Colorado 80045
Georgetown University CRS (GU CRS) Washington D.C. District of Columbia 20007
Univ. of Hawaii at Manoa, Leahi Hosp. Honolulu Hawaii 96816
Northwestern University CRS Chicago Illinois 60611
Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis Indiana 46202-5250
Indiana Univ. School of Medicine, Wishard Memorial Indianapolis Indiana 46202-5250
Johns Hopkins University CRS Baltimore Maryland 21205
Massachusetts General Hospital CRS (MGH CRS) Boston Massachusetts 02114
Brigham and Women's Hosp. ACTG CRS Boston Massachusetts 02115
Beth Israel Deaconess Med. Ctr., ACTG CRS Boston Massachusetts 02215
Washington University Therapeutics (WT) CRS St Louis Missouri 63110-1010
Univ. of Nebraska Med. Ctr., Durham Outpatient Ctr. Omaha Nebraska 68198-9500
Beth Israel Med. Ctr., ACTU New York New York 10003
Weill Cornell Chelsea CRS New York New York 10011
NY Univ. HIV/AIDS CRS New York New York 10016
Weill Cornell Uptown CRS New York New York 10021
Columbia P&S CRS New York New York 10032-3732
Trillium Health ACTG CRS Rochester New York 14607
McCree McCuller Wellness Ctr. at the Connection, Infectious Disease Unit Rochester New York 14642
Univ. of Rochester ACTG CRS Rochester New York 14642
Chapel Hill CRS Chapel Hill North Carolina 27599
Cincinnati CRS Cincinnati Ohio 45267-0405
MetroHealth CRS Cleveland Ohio 44109
Univ. of Pennsylvania Health System, Presbyterian Med. Ctr. Philadelphia Pennsylvania 19104
University of Pittsburgh CRS Pittsburgh Pennsylvania 15213
The Miriam Hospital Clinical Research Site (TMH CRS) CRS Providence Rhode Island 02906
Vanderbilt Therapeutics (VT) CRS Nashville Tennessee 37204
Univ. of Texas Southwestern Med. Ctr., Amelia Court Continuity Clinic Dallas Texas 75235-9173
Univ. of Texas Medical Branch, ACTU Galveston Texas 77555-0435

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00078403, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 7, 2021 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00078403 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →